Optimising the Nadroparin Dose for Thromboprophylaxis During Hemodialysis by Developing a Population Pharmacodynamic Model Using Anti-Xa Levels

INTRODUCTION: The optimal nadroparin dose in patients undergoing hemodialysis is difficult to determine in clinical practice. Anti-Xa levels ≥ 0.4 IU/mL and < 2.0 IU/mL are suggested to prevent thrombus formation within the extracorporeal circuit whilst minimizing bleeding risk. We aimed to chara...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaspers, Tessa C. C., Meijer, Charlotte E., Vleming, Louis Jean, Franssen, Casper F. M., Diepstraten, Jeroen, Lukens, Michael V., van den Bemt, Patricia M. L. A., Maat, Barbara, Khorsand, Nakisa, Touw, Daniël J., Koomen, Jeroen V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652168/
https://www.ncbi.nlm.nih.gov/pubmed/36040615
http://dx.doi.org/10.1007/s40262-022-01162-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652168/
https://www.ncbi.nlm.nih.gov/pubmed/36040615
http://dx.doi.org/10.1007/s40262-022-01162-x

Ejemplares similares